Article 1
1. In accordance with Commission Decision 2001/300/EC, Trust Fund 911100/MTF/INT/003/EEC shall be used for the following actions: (a) the purchase of 1500000 doses of AlOH3-adjuvated trivalent vaccine against foot-and-mouth disease virus of types O1, A-Iran 96 and ASIA 1 with a potency of 6 PD50; (b) the delivery of 1300000 doses of the vaccine referred to in subparagraph (a) to the Pendik Institute in Turkey for emergency vaccination carried out in Turkish Thrace, notably the provinces of Edirne, Kirklareli, Tekirdag and the European parts of the provinces of Canakkale and Istanbul, in accordance with the vaccination programme submitted to the Commission by the Turkish competent authorities; (c) the storage at the manufacturer's premises of 200000 doses of the vaccine referred to in subparagraph (a) for emergency vaccination where and when required by the epidemiological situation; (d) an on-the-spot inspection of the vaccination campaign by European experts, and (e) the organisation by the Turkish authorities of a serological surveillance to monitor the vaccination campaign and to substantiate the disease situation. 2. The Director-General of the Health and Consumer Protection Directorate-General shall be authorised to conclude with the European Commission for the Control of Foot-and-Mouth Disease (EUFMD) the Food and Agriculture Organisation (FAO) the necessary arrangements for the implementation of the measures provided for in paragraph 1.